Skip to content
Disclosery

Paradigm Biocapital Advisors LP: CRNX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on CRNX, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 0 CRNX shares at 2026-03-31 per its 13F-HR filed 2026-05-15.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -2,210,774 shares

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 2,210,774 shares
    Change vs previous 13F -340,000 shares

    2.76% of the 13F portfolio, value $102,911,530.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 2,550,774 shares
    Change vs previous 13F +207,221 shares

    3.14% of the 13F portfolio, value $106,239,737.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 2,343,553 shares
    Change vs previous 13F +397,385 shares

    2.88% of the 13F portfolio, value $67,400,584.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 1,946,168 shares
    Change vs previous 13F +35,407 shares

    3% of the 13F portfolio, value $65,274,475.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-12-31
    13F 1,910,761 shares
    Change vs previous 13F -605,925 shares

    3.4% of the 13F portfolio, value $97,697,210.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-09-30
    13F 2,516,686 shares
    Change vs previous 13F not available

    4.5% of the 13F portfolio, value $128,602,655.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).